ATE252642T1 - Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen - Google Patents

Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen

Info

Publication number
ATE252642T1
ATE252642T1 AT00956156T AT00956156T ATE252642T1 AT E252642 T1 ATE252642 T1 AT E252642T1 AT 00956156 T AT00956156 T AT 00956156T AT 00956156 T AT00956156 T AT 00956156T AT E252642 T1 ATE252642 T1 AT E252642T1
Authority
AT
Austria
Prior art keywords
epec
enteropathogenic
coli
intimin
strains
Prior art date
Application number
AT00956156T
Other languages
English (en)
Inventor
Jonas Marien
Johan Peeters
Dominique Vandekerchove
Wim Stakenborg
Original Assignee
Ct Voor Onderzoek In Diergenee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Voor Onderzoek In Diergenee filed Critical Ct Voor Onderzoek In Diergenee
Application granted granted Critical
Publication of ATE252642T1 publication Critical patent/ATE252642T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00956156T 1999-06-02 2000-06-02 Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen ATE252642T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99870111A EP1057892A1 (de) 1999-06-02 1999-06-02 Attenuierte mutante enteropathogenische E.coli-Stämme (EPEC), deren Herstellungsverfahren und Verwendungen
PCT/EP2000/005061 WO2000073462A2 (en) 1999-06-02 2000-06-02 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use

Publications (1)

Publication Number Publication Date
ATE252642T1 true ATE252642T1 (de) 2003-11-15

Family

ID=8243841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956156T ATE252642T1 (de) 1999-06-02 2000-06-02 Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen

Country Status (6)

Country Link
EP (2) EP1057892A1 (de)
AT (1) ATE252642T1 (de)
AU (1) AU6821300A (de)
DE (1) DE60006101D1 (de)
ES (1) ES2209954T3 (de)
WO (1) WO2000073462A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207436A (pt) * 2001-12-21 2004-06-01 Nestle Sa Bactérias de ácido lático para prevenção de infecção com patógenos expressando intimina
KR100471115B1 (ko) * 2001-12-26 2005-03-08 주식회사 단바이오텍 장병원성 대장균 감염의 예방 및 치료를 위한 수용성단백질 및 이를 포함한 알 및 이들의 제조방법
CN116024151B (zh) * 2022-12-13 2024-01-26 南通大学 一种禽致病性大肠杆菌sRNA s078基因缺失菌株及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes

Also Published As

Publication number Publication date
EP1181371A2 (de) 2002-02-27
EP1057892A1 (de) 2000-12-06
AU6821300A (en) 2000-12-18
WO2000073462A2 (en) 2000-12-07
WO2000073462A9 (en) 2002-09-06
ES2209954T3 (es) 2004-07-01
EP1181371B1 (de) 2003-10-22
WO2000073462A3 (en) 2001-06-28
DE60006101D1 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
MXPA03000103A (es) Antigenos de streptococcus.
WO2000039299A3 (en) Streptococcus antigens
WO1999042588A3 (en) Group b streptococcus antigens
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
WO2002083855A3 (en) Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
ATE317013T1 (de) Antigen omp26 aus haemophilus influenzae
AU6867801A (en) Fusion proteins of mycobacterium tuberculosis
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
AU3607301A (en) Gene recombinant antibody and its fragment
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
PT914437E (pt) Identificacao e clonagem de um antigenio micobacteriano correspondente a uma hemaglutinina de ligacao a heparina
BR0205083A (pt) Polipeptìdeo isolado, composição farmacêutica, proteìna de fusão, polinucleotìdeo isolado, vetor de expressão, célula hospedeira recombinante e métodos de produzir um polipeptìdeo, de detectar a presença da expressão de gene em uma amostra biológica, de expandir células monocìticas ou progenitores de células de monócitos e de estimular uma resposta imune em um mamìfero exposto a um antìgeno ou patógeno
ATE252642T1 (de) Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen
WO1995006726A3 (en) Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
ATE547527T1 (de) Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
CA2347278A1 (en) Vaccine based on attenuated haemophilus somnus
EP1950302A3 (de) Streptokokken-Antigene
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2002030321A3 (en) Bird diagnostics and treatments
PT592574E (pt) Processo de producao de proteinas recombinantes e celulas hospedeiras utilizadas
TH83327A (th) การก่อภูมิคุ้มกันของวัวนมด้วยไคเมริกโปรตีน GapC ต่อการติดเชื้อ สเทรปโทคอกคัส

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties